Meningeal carcinomatosis in patients with breast carcinoma: Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen

Cancer

Volumn 77, Issue 7, 1996, Pages 1315-1323

  Fizazi, Karim ^a   Asselain, Bernard ^a   Vincent Salomon, Anne ^a   Jouve, Michel ^a   Dieras, Véronique ^a   Palangie, Thao ^a   Beuzeboc, Philippe ^a   Dorval, Thierry ^a   Pouillart, Pierre ^a  

^a INSTITUT CURIE   (France)

Author keywords

breast carcinoma; chemotherapy; intrathecal methotrexate; leptomeningeal metastases; lobular carcinoma; meningeal carcinomatosis; prognostic factor

Indexed keywords

FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; INJECTIONS, SPINAL; LEUCOVORIN; MENINGEAL NEOPLASMS; METHOTREXATE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0029879701     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4     Document Type: Article

References (40)

1. Kaplan JG, Desouza TG, Farkash A, Shafran B, Pack D, Rehman F, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemia. J Neurooncol 1990; 9:225-9.
2. Pouillart P, Palangie T, Scholl S, Belli L, Beuzeboc P, Jouve M, et al. Association de 5 fluorouracile administré en perfusion continue, de vindesine et de cyclophosphamide dans le traitement des cancers du sein métastasés. Etude de la réponse selon les sites métastatiques. Bull Cancer 1989; 76: 191-5.
3. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979:319. WHO Offset Publication No. 48.
4. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
5. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 1970; 57:579-94.
6. Wasserstrom WR, Glass P, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982; 49:759-72.
7. Yap HY, Yap BS, Rasmussen S, Levens ME, Hortobagyi GN, Blumenschein GR. Treatment for meningeal carcinomatosis in breast cancer. Cancer 1982; 49:219-22.
8. Ongerboer de Visser BW, Somers R, Nooyen WH, Van Heerde P, Hart AAM, McVie G. Intraventricular methotrexate therapy of the leptomeningeal metastasis from breast carcinoma. Neurology 1983; 33:1365-72.
9. Clamon G, Doebbeling B. Meningeal carcinomatosis from breast cancer: spinal cord versus brain involvement. Breast Cancer Res Treat 1987;9:213-7.
10. Schabet M, Kloeter I, Adam T, Heidemann E, Wiethöcter H. Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer. Eur Neurol 1986; 25:403-11.
11. Boogerd W, Hart AAM, Van der Sande JJ, Engelsman E. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991; 67:1685-95.
12. Jayson GC, Howell A, Harris M, Morgenstern G, Chang J, Ryder W. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer 1994; 74:3135-41.
13. Gonzalez-Vitale JC, Garcia-Bunnel R. Meningeal carcinomatosis. Cancer 1976; 37:2906-11.
14. Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987; 5:1655-62.
15. Yap HY, Yap BS, Tashima CK, Di Stefano A, Blumenschein GR. Meningeal carcinomatosis in breast cancer. Cancer 1978; 42:283-6.
16. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983; 52:2349-54.
17. Grant R, Naylor B, Greeberg HS, Junck L. Clinical outcome in aggressiveiy treated meningeal carcinomatosis. Arch Neurol 1994; 51:457-61.
18. Kokkoris CP. Leptomeningeal carcinomatosis: how does cancer reach the piaarachnoid? Cancer 1983; 51:154-60.
19. Harris M, Howell A, Chrissohou M, Swindell RIC, Hudson M, Sellwood RA. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50:23-30.
20. McGuire WL. Current status of oestrogen receptors in human breast cancer. Cancer 1975; 36:638-44.
21. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL. Moynihan T, Ettinger DS. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993; 11:561-9.
22. Lishner M, Perrin RG, Feld R, Messner HA, Tuffnel PG, Path FRC, et al. Complications associated with Ommaya reservoirs in patients with cancer. Arch Intern Med 1990; 150:173-6.
23. Obbens EAMT, Leavens ME, Beal JW, Lee Y. Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 1985; 35:1274-8.
24. Trump DL, Grossman A, Thompson G, Murray K. CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy. Arch Intern Med 1982; 142:583-6.
25. Steward DJ, Maroun JA, Hugenholtz H, Benoit B, Girard A, Richard M, et al. Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies. J Neuro Oncol 1987; 5:315-22.
26. Shapiro WR, Posner JB, Ushio Y, Chernik NL, Young DF. Treatment of meningeal neoplasms. Cancer Treat Rep 1977; 61:733-43.
27. Gutin PH, Levi JA, Wiernik PH, Walker MD. Treatment of malignant meningeal disease with intrathecal thio-TEPA: a phase II study. Cancer Treat Rep 1977; 61:885-7.
28. Fulton DS, Levin VA, Gutin PH, Edwards MSB, Seager ML, Stewart J, et al. Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol 1982:8: 285-91.
29. Nakagawa H, Murasawa A, Kubo S, Nakajima S, Nakajima Y, Izumoto S. Diagnosis and treatment of patients with meningeal carcinomatosis. J Neuro Oncol 1992; 13:81-9,
30. Giannone L, Greco FA, Hainsworth JD. Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 1986; 4:68-73.
31. Sorensen SC, Eagan RT, Scott M. Meningeal carcinomatosis in patients with primary breast or lung cancer. Mayo Clin Proc 1984; 59:91-4.
32. Bleyer WA, Poplack DG, Simon RG. "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 1978; 51:835-42.
33. Mehta BM, Glass JP, Shapiro WR. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. Cancer Res 1983; 43:435-8.
34. Grossman SA, Trump DL, Chen DCP, Thompson G, Camargo EE. Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. Am J Med 1982; 73:641-7.
35. Blasberg RG, Patlak C, Fenstermacher JD. Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion. Pharm Exp Ther 1975; 195:73-83.
36. Ushio Y, Shimizu K, Aragaki Y, Arita N, Hayakawa T, Mogami H. Alteration of blood-CSF barrier by tumor invasion into the meninges. J Neurosurg 1981; 55:445-9.
37. Siegal T, Sandbank U, Gabizon A, Siegal T, Mizrachi R, BenDavid E, et al. Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study. J Neuro Oncol 1987; 4:233-42.
38. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981; 65:89-98.
39. Boogerd W, Van der Sande JJ, Moffie D. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate. J Neurol Neurosurg Psychiatry 1988; 51:1277-83.
40. Sause WT, Cowley J, Eyre HJ, Rivkin SE, Pugh RP, Quagliana JM, et al. Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases. A Southwest Oncology Group study. J Neuro Oncol 1988; 6:107-12.